Brief Article
Copyright ©2013 Baishideng Publishing Group Co.
World J Cardiol. Jun 26, 2013; 5(6): 196-206
Published online Jun 26, 2013. doi: 10.4330/wjc.v5.i6.196
Table 4 Hemorrhagic and combined event rates according to the BLEED-myocardial infarction score risk-group stratification
CategoryLow riskIntermediate riskHigh riskGamma for trendP value
Clinically significant bleeding events
Derivation cohort (follow-up: 19.9 ± 6.7 mo)Incidence0.80%3.40%14.40%0.70 ± 0.08< 0.001
Validation cohort (follow-up: 13.4 ± 8.1 mo)Incidence1.30%5.00%14.10%0.61 ± 0.08< 0.001
Composite endpoint (bleeding + all-cause mortality)
Derivation cohort (follow-up: 19.9 ± 6.7 mo)Incidence3.10%11.40%45.70%0.76 ± 0.04< 0.001
Validation cohort (follow-up: 13.4 ± 8.1 mo)Incidence1.30%9.30%31.30%0.73 ± 0.05< 0.001